Folgen
Gwenn S. Smith, PhD
Gwenn S. Smith, PhD
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
Bestätigte E-Mail-Adresse bei jhmi.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
ND Volkow, RC Gur, GJ Wang, JS Fowler, PJ Moberg, YS Ding, ...
American Journal of psychiatry 155 (3), 344-349, 1998
9981998
A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease
AW Laxton, DF Tang‐Wai, MP McAndrews, D Zumsteg, R Wennberg, ...
Annals of neurology 68 (4), 521-534, 2010
7842010
Serotonin in aging, late-life depression, and Alzheimer’s disease: the emerging role of functional imaging
MD Carolyn Cidis Meltzer, G Smith, ST DeKosky, BG Pollock, CA Mathis, ...
Neuropsychopharmacology 18 (6), 407-430, 1998
6091998
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation.
MJ De Leon, J Golomb, AE George, A Convit, CY Tarshish, T McRae, ...
American Journal of Neuroradiology 14 (4), 897-906, 1993
4501993
Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment
Z Ismail, EE Smith, Y Geda, D Sultzer, H Brodaty, G Smith, L Agüera-Ortiz, ...
Alzheimer's & Dementia 12 (2), 195-202, 2016
4352016
Animal models of Alzheimer's disease: experimental cholinergic denervation
G Smith
Brain Research Reviews 13 (2), 103-118, 1988
4181988
Miller 634 DC (1989) Early marker for Alzheimer’s disease: The 635 atrophic hippocampus
MJ De Leon, AE George, LA Stylopoulos, G Smith
Lancet 2, 672-673, 0
379*
Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels
SL Dewey, GS Smith, J Logan, JD Brodie, JS Fowler, AP Wolf
Synapse 13 (4), 350-356, 1993
3311993
Dopamine transporters decrease with age
ND Volkow, YS Ding, JS Fowler, GJ Wang, J Logan, SJ Gatley, ...
Journal of Nuclear Medicine 37 (4), 554-559, 1996
3261996
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future
YE Geda, LS Schneider, LN Gitlin, DS Miller, GS Smith, J Bell, J Evans, ...
Alzheimer's & dementia 9 (5), 602-608, 2013
2892013
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging.
H Rusinek, MJ De Leon, AE George, LA Stylopoulos, R Chandra, G Smith, ...
Radiology 178 (1), 109-114, 1991
2881991
Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial
N Lipsman, DB Woodside, P Giacobbe, C Hamani, JC Carter, ...
The Lancet 381 (9875), 1361-1370, 2013
2842013
Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction
CC Meltzer, MN Cantwell, PJ Greer, D Ben-Eliezer, G Smith, G Frank, ...
Journal of Nuclear Medicine 41 (11), 1842-1848, 2000
2602000
Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis
SL Dewey, GS Smith, J Logan, D Alexoff, YS Ding, P King, N Pappas, ...
Journal of Neuroscience 15 (1), 821-829, 1995
2581995
Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects
GS Smith, R Schloesser, JD Brodie, SL Dewey, J Logan, SA Vitkun, ...
Neuropsychopharmacology 18 (1), 18-25, 1998
2561998
Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging
ND Volkow, GJ Wang, JS Fowler, YS Ding, RC Gur, J Gatley, J Logan, ...
Annals of Neurology: Official Journal of the American Neurological …, 1998
2521998
GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography
SL Dewey, GS Smith, J Logan, JD Brodie, DW Yu, RA Ferrieri, PT King, ...
Journal of Neuroscience 12 (10), 3773-3780, 1992
2441992
A phase II study of fornix deep brain stimulation in mild Alzheimer’s disease
AM Lozano, L Fosdick, MM Chakravarty, JM Leoutsakos, C Munro, E Oh, ...
Journal of Alzheimer's Disease 54 (2), 777-787, 2016
2422016
The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations
Z Ismail, L Agüera-Ortiz, H Brodaty, A Cieslak, J Cummings, CE Fischer, ...
Journal of Alzheimer's disease 56 (3), 929-938, 2017
2312017
Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease: pathophysiologic implications
GS Smith, MJ de Leon, AE George, A Kluger, ND Volkow, T McRae, ...
Archives of neurology 49 (11), 1142-1150, 1992
2281992
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20